Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice
about
Peripheral cannabinoid receptor, CB2, regulates bone mass.osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcificationHormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation.Follicle-stimulating hormone, interleukin-1, and bone density in adult women.Central IL-1 receptor signaling regulates bone growth and massPhysiology of bone loss.Female reproductive system and bone.Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptorCytokine-mediated bone destruction in rheumatoid arthritis.A novel in vivo gene transfer technique and in vitro cell based assays for the study of bone loss in musculoskeletal disordersTransplantation of SHED prevents bone loss in the early phase of ovariectomy-induced osteoporosis.Protection by salidroside against bone loss via inhibition of oxidative stress and bone-resorbing mediators.Tumor necrosis factor-α signaling in macrophages.Novel functions for NFκB: inhibition of bone formationCyclin G2 suppresses estrogen-mediated osteogenesis through inhibition of Wnt/β-catenin signaling.M-CSF neutralization and egr-1 deficiency prevent ovariectomy-induced bone loss.Requirement for NF-kappaB in osteoclast and B-cell developmentMicroarray analysis of human adipose-derived stem cells in three-dimensional collagen culture: osteogenesis inhibits bone morphogenic protein and Wnt signaling pathways, and cyclic tensile strain causes upregulation of proinflammatory cytokine regulThe anti-inflammatory role of vitamin e in prevention of osteoporosis.Ovariectomy enhances and estrogen replacement inhibits the activity of bone marrow factors that stimulate prostaglandin production in cultured mouse calvariae.Interactions between the immune system and bone.A crucial role for thiol antioxidants in estrogen-deficiency bone loss.The Anti-Inflammatory, Phytoestrogenic, and Antioxidative Role of Labisia pumila in Prevention of Postmenopausal Osteoporosis.Estrogen and the skeletonLabisia pumila Prevents Complications of Osteoporosis by Increasing Bone Strength in a Rat Model of Postmenopausal Osteoporosis.CCR-2 neutralization augments murine fresh BMC activation by Staphylococcus aureus via two distinct mechanisms: at the level of ROS production and cytokine response.The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesisInterleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formationIL-1 receptor-associated kinase M is a central regulator of osteoclast differentiation and activation.Bone remodeling in post-menopausal osteoporosis.Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency.Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD.Regulatory pathways associated with bone loss and bone marrow adiposity caused by aging, chemotherapy, glucocorticoid therapy and radiotherapy.Effects of estradiol on reduction of osteoarthritis in rabbits through effect on matrix metalloproteinase proteins.TNF signaling contributes to the development of nociceptive sensitization in a tibia fracture model of complex regional pain syndrome type IEstrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha.IL-18BP is decreased in osteoporotic women: Prevents Inflammasome mediated IL-18 activation and reduces Th17 differentiation.The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis.Human blood-mobilized hematopoietic precursors differentiate into osteoclasts in the absence of stromal cells.
P2860
Q24536360-916718D6-2700-4407-A5EC-01B37064E3CAQ24603266-EC10B4E6-50CD-4810-9B43-454F44B648DFQ24804802-40D8A9F1-3066-456E-9441-AE96C389EF42Q31717820-A7701FEA-52FF-47F0-BA62-E5F5CF71B745Q33728125-9E410C89-EDC1-4785-8419-85C78BB87231Q33943828-4956B4FD-45F9-46BF-8F17-D7BC89A44E65Q33980978-FE5BC788-7631-4E9F-8C02-39FDA5EA232AQ34142868-0C1A7B58-AF1A-481F-BCC4-87535B81414DQ34224435-3EE190B4-5675-4AA7-B9BB-721675F4DCF5Q34252489-C1F8FC47-426C-477A-91E1-C7488A2362BBQ34299772-5F726339-48C1-4A3F-A3C0-4DDDD0FB3903Q34418727-71ED30D4-DB79-4877-AB4A-94EB344646DFQ34600281-10447D7C-1353-49C5-B7AD-E6323CFF616CQ34734335-3A35F341-3FA7-413E-B30A-C4A3B31106C7Q34806538-BC294DD4-9F82-440F-BB93-2122B5AA4E3FQ35111337-C1B4398C-203D-4D5A-8CFB-E2243A24C3BAQ35159009-AED9CCDA-F9EF-4894-8D80-2E66D8A8424BQ35199657-B06C3D96-8600-4D61-9DD9-C04E11F65E5EQ35476764-A8B7DB4A-D202-4186-BB2D-76CE2A9FF2BDQ35580008-903540AB-D81A-4B1B-8841-5A136F72D36BQ35751206-CD977FCC-40DC-4910-B285-80E3EE566E4CQ35825391-2D945876-E772-49FC-9E42-E755A1340E9DQ35919837-952F7009-C93B-46A2-803D-67E41187A85EQ35963142-684182EF-0AE4-41F1-A243-E9437702A57CQ36179747-70963E45-EA8B-437E-A33C-6232D8EE689EQ36238850-DE4536D3-64A3-4EDB-AA81-575A5A0ED9F0Q36346773-52BD5A6A-691C-43F6-94E3-323D2EB865D3Q36371653-E7BA2B18-6EC8-4EAA-9257-E3C8E21ADFD0Q36377004-BF20BA89-85DA-4D93-91EF-A2E3DFE59121Q36403428-F62E2000-7B66-47B8-8FB2-3B941608D76EQ36518536-A1EBDA97-3C9D-4308-8E34-2A751CFCB6DAQ36566505-62A077EB-4A6F-4D93-B834-D38C50B02427Q36736233-8191607F-64A0-4140-991B-7F39BC709F9FQ36796392-7F1BF4E8-19D8-42DA-B972-F441F2F642EEQ36805188-E54CCBFB-6199-4E76-BBF6-5A105F80ACB3Q36862101-32C46388-8263-44C9-9206-8C9F9B750E5FQ37271202-22E493B9-450B-4D87-A0E5-EF10B6F3190EQ37271285-A57D7D01-F064-47E1-BE28-34BDF481E35FQ37287589-F785CC15-51B1-4AAC-A3BF-594DCDEEB5A5Q37295785-9009446D-0868-4690-A8C0-E32528CECBB5
P2860
Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Interleukin-1 receptor antagon ...... orption in ovariectomized mice
@ast
Interleukin-1 receptor antagon ...... orption in ovariectomized mice
@en
type
label
Interleukin-1 receptor antagon ...... orption in ovariectomized mice
@ast
Interleukin-1 receptor antagon ...... orption in ovariectomized mice
@en
prefLabel
Interleukin-1 receptor antagon ...... orption in ovariectomized mice
@ast
Interleukin-1 receptor antagon ...... orption in ovariectomized mice
@en
P2093
P2860
P356
P1476
Interleukin-1 receptor antagon ...... orption in ovariectomized mice
@en
P2093
J L Vannice
R B Kimble
R Kitazawa
R Pacifici
P2860
P304
P356
10.1172/JCI117606
P407
P577
1994-12-01T00:00:00Z